DePriest Anne Z, Black David L, Robert Timothy A
Aegis Sciences Corporation, Nashville, Tennessee; College of Pharmacy, University of Tennessee, Memphis, Tennessee.
Aegis Sciences Corporation, Nashville, Tennessee; Department of Pathology, Immunology and Microbiology, Vanderbilt University, Nashville, Tennessee.
J Opioid Manag. 2015 Jan-Feb;11(1):13-25. doi: 10.5055/jom.2015.0248.
Immunoassay is used extensively for drug testing in pain management. Drug testing for the purpose of compliance monitoring is fundamentally different from forensic applications, which may rely on immunoassay screening to rapidly identify "negative" samples. In clinical settings, focus is shifted from identification of select drugs of abuse with low positivity rates to detection of a wide variety of licit and illicit compounds with expected high positivity rates. The primary drug classes of interest in this population, opioids and benzodiazepines, require special testing considerations when immunoassay is used. This review highlights the performance characteristics of immunoassay, with special emphasis on prescription drug classes and testing at the point-of-care.
免疫测定在疼痛管理的药物检测中被广泛应用。用于合规监测目的的药物检测与法医应用有着根本的不同,法医应用可能依赖免疫测定筛查来快速识别“阴性”样本。在临床环境中,重点从识别阳性率低的特定滥用药物转向检测各种预期阳性率高的合法和非法化合物。该人群中主要关注的药物类别,即阿片类药物和苯二氮䓬类药物,在使用免疫测定时需要特殊的检测考虑。本综述重点介绍了免疫测定的性能特征,特别强调了处方药类别和即时检测。